SCHEMBL30846288

SCHEMBL30846288

Cn1ncc2cccc(NS(=O)(=O)c3ccc(-c4ccc(O)nc4)nc3)c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.38
▸ UQCRB P14927 1/20 0.38
▸ SLC40A1 Q9NP59 6/20 0.38
▸ KMT2A Q03164 3/20 0.35
▸ LMNA P02545 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ MITF O75030 1/20 0.35
▸ S1PR4 O95977 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ S1PR1 P21453 1/20 0.35
▸ AGTR1 P30556 1/20 0.35
▸ OPRK1 P41145 1/20 0.35
▸ CKS1B P61024 1/20 0.35
▸ SKP2 Q13309 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ GLO1 Q04760 1/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ MMP2 P08253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27118277 1.00 GAA (0.38) GAAUQCRBSLC40A1KMT2ALMNA
SCHEMBL30846341 0.89 SLC40A1 (0.41) SLC40A1KMT2ALMNAMAPTHTT
SCHEMBL27118142 0.89 SLC40A1 (0.41) SLC40A1KMT2ALMNAMAPTHTT
SCHEMBL27119245 0.88 GAA (0.48) GAASLC40A1KMT2ALMNAALDH1A1
SCHEMBL30846276 0.88 SLC40A1 (0.40) GAASLC40A1KMT2ALMNAMAPT
SCHEMBL27118195 0.88 SLC40A1 (0.40) GAASLC40A1KMT2ALMNAMAPT
SCHEMBL30846255 0.86 EIF2AK3 (0.48) SLC40A1LMNAMAPTGLO1MAPK1
SCHEMBL27119198 0.86 EIF2AK3 (0.48) SLC40A1LMNAMAPTGLO1MAPK1
SCHEMBL27118018 0.86 PTGES2 (0.46) GAASLC40A1KMT2ALMNAMAPT
SCHEMBL30846465 0.85 SLC40A1 (0.40) GAASLC40A1KMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024044344-A1 PYRIDINYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 — — WO disclosed
Send feedback